Business & Finance

CoTherix reports increasing Ventavis sales, provides Q4 and 2005 results

Published in Blood Weekly, April 13th, 2006

CoTherix, Inc., (CTRX) reported results for its fourth quarter and year ended December 31, 2005. Net product sales from the company's Ventavis Inhalation Solution in the fourth quarter of 2005 were $11 million, up 30% from $8.4 million in the third quarter of 2005.

Total 2005 net product sales for Ventavis, which was launched in March 2005, were $23.9 million.

"[Last year] was a tremendous year for CoTherix as we successfully transitioned into a commercial organization with the launch of Ventavis for pulmonary arterial hypertension. We've established critical talent in sales, marketing, and reimbursement and intend to leverage this commercial...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2006-04-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry